Unspecified protozoal and cancer-related cellular machinery

The term "Unspecified protozoal and cancer-related cellular machinery" does not refer to a single, defined molecular target such as a specific receptor, enzyme, or ion channel. Instead, it serves as a broad, descriptive category for biological processes or structural components that are common to both protozoan parasites and neoplastic human cells. Many drugs, particularly those identified through phenotypic screening or repurposing efforts, exhibit dual activity against parasitic infections (e.g., malaria, leishmaniasis) and various cancers by interfering with conserved eukaryotic processes. These processes often include DNA replication, protein synthesis, microtubule assembly, or metabolic pathways like folate synthesis. Because this entry lacks a specific protein or gene identifier, it is considered an incorrect or overly broad target designation for drug development and bioinformatics purposes. Precise therapeutic targeting requires the identification of specific molecular entities to ensure efficacy and minimize off-target effects.

Other names

Unspecified protozoal machineryUnspecified cancer-related machinery

Unknown